INNOVATION SPOTLIGHT: SCOTT POMERANTZ, MC10
Why is MC10 participating in the d.health Summit 2016?
MC10 is proud to announce a partnership with the University of Rochester, and will be working closely with Ray Dorsey and other research faculty on MC10-enabled solutions to improving healthcare. The collaboration unites MC10’s powerful technological capabilities in physiological sensing and pattern recognition algorithms with the University of Rochester’s clinical expertise and commitment to data analytics to drive solutions for today’s most pressing healthcare challenges. The incredible thought leadership and disruptive approach to problem solving represented at the d.health Summit is what drew MC10 to both this event and the UR collaboration.
Tell us your disruptive innovation story. What is MC10 working on that will change the game for healthcare and/or for Aging Americans?
More than ever before, we are driven to develop effective, safe, and economical solutions to healthcare challenges such as chronic disease management and the treatment of costly conditions, whose burden is felt disproportionately by Aging Americans.
Our belief is that these new therapeutic approaches are ultimately going to depend on high-quality, quantitative data coming directly from the patient’s body being merged with contextual information to quantify important personal metrics such as activity, vital signs, and other measures of therapeutic effect. Fundamentally, these metrics can only be leveraged in a widespread and impactful way through the use of comfortable, easily deployed, and accurate sensing approaches that a patient or caregiver can apply, and forget about until it is time to download the derived insights in a user-friendly way.
According to AARP, 89% of people 50 years and older want to receive care from the home. MC10 brings healthcare into the home with products that unite consumer design with clinical-grade sensing and insight. Our BioStamp™ platform can collect human physiological data from any body location to deliver actionable health insights. We are focused on the potential of our BioStamp technology to change the way that healthcare is delivered, by making personalized physiological feedback as routine as brushing your teeth.
At MC10, we realize our greatest innovations through partnerships with leading healthcare organizations and research institutions. An example of this is our collaboration with pharmaceutical company UCB, where we are currently undergoing clinical trials to evaluate the BioStamp platform for patient-focused disease management solutions. Our target audience is patients of neurological diseases, where accurate measurement of the magnitude and frequency of body movement is critical to assessing treatment and helping patients to become more actively engaged in care. Today’s monitoring technologies are bulky, cumbersome, and typically found in clinical settings. Outside of the hospital, patients are presented with the burden of interpreting and manually tracking symptoms in a diary or notebook. MC10’s seamless and wearable monitoring solutions have the power to enable patients of neurological diseases to keep better track of their health, and incentivize them to properly adhere to therapy.
What do you see as the single most untapped opportunity in healthcare today?
Patients are the most underutilized resource in healthcare today. Individuals have long expressed their desire to co-produce their care with their doctors, utilizing resources like WebMD and self-tracking tools and diaries. But as modern technology has become more prevalent, consumers increasingly have access to tools that not only empower care management from the home, but that can finally earn them a seat at the table with their doctor. Connected health monitoring devices will provide consumers with relevant data regarding their health, just as they have the data and information to manage their own finances. And in an era of reimbursement for outcomes, physicians increasingly want access to this kind of data to optimize the diagnosis and treatment of their patient population.
What do you see as the biggest obstacle to improving healthcare for Aging Americans?
This is a complex, multidisciplinary problem that we are solving— and that is what makes it worthwhile, as it crosses medicine, biology, chemistry, mechanics, electronics, and materials science. It is precisely the kind of innovation that is required to bring cutting edge and transformational technology to the forefront of practical medicine, whereby patients can gain control of their own care and self-manage. This will reduce the burden on our healthcare system, and offer better, more personalized therapy.